Literature DB >> 3809993

Participation in mass screening for colorectal cancer with fecal occult blood test.

K Klaaborg, M S Madsen, O Søndergaard, O Kronborg.   

Abstract

A Danish, randomized study with Hemoccult-II, including 60,000 persons between 45 and 74 years old, began in 1985. Methods of increasing acceptability are described for the first 8000. The first 1000 refusals are also analyzed. Written invitations including prestamped envelopes for return of the slides resulted in an acceptability of 58.8%. Two reminders increased the figure to 65.6%. Personal attempts to change the mind of those refusing increased the last figure to 68.9%. Incomplete slides were returned by 49 persons, but on request 43 sent a complete set. All 78 persons with positive tests had colonoscopy, which detected carcinomas in 10 and adenomas in 39. The study confirmed that results of trials from different countries are difficult to compare because of major differences among populations and methods. However, the present results were similar to those obtained in a Swedish study including only persons between 60 and 64 years old.

Entities:  

Mesh:

Year:  1986        PMID: 3809993     DOI: 10.3109/00365528608996440

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  6 in total

1.  Screening of colorectal tumours using an improved faecal occult blood test. Quantitative aspects.

Authors:  I Häkkinen; R Paasivuo; P Partanen
Journal:  Gut       Date:  1988-09       Impact factor: 23.059

Review 2.  Colorectal carcinoma and Haemoccult. A study of its value in mass screening using meta-analysis.

Authors:  J Windeler; J Köbberling
Journal:  Int J Colorectal Dis       Date:  1987-11       Impact factor: 2.571

3.  Screening for colorectal cancer: reasons for refusal of faecal occult blood testing in a general practice in England.

Authors:  K A Hynam; A R Hart; S P Gay; A Inglis; A C Wicks; J F Mayberry
Journal:  J Epidemiol Community Health       Date:  1995-02       Impact factor: 3.710

4.  A simple strategy to improve patient adherence to outpatient fecal occult blood testing.

Authors:  J D Freedman; C K Mitchell
Journal:  J Gen Intern Med       Date:  1994-08       Impact factor: 5.128

5.  Colorectal cancer screening in asymptomatic populations.

Authors:  A R Hart; A C Wicks; J F Mayberry
Journal:  Gut       Date:  1995-04       Impact factor: 23.059

6.  Adenomas and hyperplastic polyps in screening studies.

Authors:  K Bech; O Kronborg; C Fenger
Journal:  World J Surg       Date:  1991 Jan-Feb       Impact factor: 3.352

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.